Also known as Cetrimide, Cetrimoni Bromidum and Tetradecyl trimethyl ammonium bromide (TTAB), FeF® Strong Cetrimide Solution 40% BP Pharma with isopropyl alcohol (CAS No. 1119-97-7) consists of around 20% dodecyl trimethyl ammonium bromide and approcimately 80% trimethyl tetradecyl ammonium bromide, as well as approximately 7.5% volume by volume (v/v) isopropyl alcohol.

Manufactured to meet current good manufacturing practice (cGMP) guideline ICH Q7 for Active Pharmaceutical Ingredients, FeF® is analysed according to the current British Pharmacopoeia (BP) requirements.

Packaging sizes:

• Item number: 7800025, 200kg drum

Documentation and services

Novo Nordisk Pharmatech provides a wide range of documentation, including:

• European drug master file (ASMF)
• Good manufacturing practice (GMP) certificate
• Certificate of Analysis (current version of Pharmacopoeia)
• Datasheets
• Customer audits
• Stability results
• Declarations and statements such as transmissible spongiform encephalopathy (TSE) / bovine spongiform encephalopathy (BSE) statements, residual solvents, genetically modified organism (GMO), allergens and animal testing
• Reach
• Change notification statement
• Pre-filled supplier questionnaires
• Impurity profile
• Description of the manufacturing process
• Process flowchart
• Packaging details
• Quality agreements